Associations (odds ratios)a of cervical cytologies without follow-up, stratified by follow-up recommendation
| Before % without follow-up | After % without follow-up | After versus before (ref) OR (95% CI) | |
|---|---|---|---|
| Recommended follow-up in 12 months, n | 3855 | 22 515 | |
| At recommended follow-up date | 78.0 | 72.8 | 0.87 (0.83 to 0.91) |
| 3 months after recommended follow-up b | 48.8 | 48.0 | 1.00 (0.96 to 1.06) |
| 6 months after recommended follow-up | 36.0 | 18.6 | 0.54 (0.50 to 0.58) |
| 9 months after recommended follow-up | 28.4 | 11.7 | 0.44 (0.39 to 0.50) |
| Recommended follow-up in 6 months, n | 6986 | 9683 | |
| At recommended follow-up date | 64.8 | 62.0 | 0.94 (0.90 to 0.97) |
| 3 months after recommended follow-up b | 28.4 | 28.0 | 0.99 (0.96 to 1.03) |
| 6 months after recommended follow-up | 18.5 | 10.9 | 0.73 (0.69 to 0.76) |
| 9 months after recommended follow-up | 14.8 | 7.0 | 0.62 (0.56 to 0.69) |
| Recommended follow-up in 3 months, n | 10 222 | 10 854 | |
| At recommended follow-up date | 62.6 | 60.1 | 0.94 (0.90 to 0.97) |
| 3 months after recommended follow-up b | 34.3 | 32.4 | 0.94 (0.91 to 0.98) |
| 6 months after recommended follow-up | 25.5 | 15.0 | 0.64 (0.59 to 0.70) |
| 9 months after recommended follow-up | 21.5 | 10.6 | 0.60 (0.55 to 0.67) |
| Recommended follow-up within 3 months, n | 11 957 | 17 673 | |
| At recommended follow-up date | 16.3 | 16.2 | 0.99 (0.95 to 1.02) |
| 1 month after recommended follow-up b | 9.7 | 10.4 | 1.04 (0.99 to 1.08) |
| 4 months after recommended follow-up | 4.4 | 3.9 | 0.93 (0.88 to 0.99) |
| 7 months after recommended follow-up | 3.3 | 2.5 | 0.87 (0.81 to 0.94) |